World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Scientific Indexing Services (SIS), Indian citation Index (ICI), Directory of Research Journals Indexing, Scintific journal impact factorScientific Journal Impact Factor (SJIF), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Cosmos Impact Factor, IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Research Bible, Fuchu, Tokyo. JAPAN, Scholar Article Journal Index (SAJI), Scope Database, Academia, 



Anitha Pendyala*, Sri Lakshmi Surekha Manchineni, Hephzibah Palli, Karthika Pamidipalli and Prasadarao Manchineni


Introduction: For patients with diabetes mellitus, a comparison between TDM and standard medication therapy is
essential to comprehending the benefits, drawbacks, and clinical consequences of each. Conventional therapy
offers standardized treatment regimens and simplicity, while target-directed medicine (TDM) delivers personalized
care, improved safety profiles, and optimum therapeutic results. Healthcare professionals can determine the best
course of action for their patients by weighing the effectiveness, safety, clinical results, and cost-efficiency of both
approaches. Methods and Material: The Present study was prospective observational study conducted at
Department of General medicine Government area hospital, Narasaraopet. This study was conducted on 102
patients. A total of 102 patients were recruited for this 45-day prospective study, with 51 patients assigned to the
TDM group and the remaining 51 patients assigned to the conventional treatment group. The primary outcome
measure for the study will be the change in HbA1c levels from baseline to the end of the 46-day period. Secondary
outcome measures will include changes in blood glucose levels, medication adherence, and adverse events.
Results: In this study, 35 – 45 years of male are being dominated with sample of 40 (39.21%) followed by 46-60
years male with sample of 36 (35.29%). The study found that patients who underwent therapeutic drug monitoring
had a greater reduction in mean blood glucose levels (from 175 mg/dL to 110 mg/dL) compared to patients who
received conventional treatment (from 170 mg/dL to 120 mg/dL). There is decreasing of the HbA1C levels from
7.2% to 5.9%, But there is worthy more changes in Therapeutic drug monitored patients from 7.1% to 4.6%.
Conclusion: The results of the study indicated that patients in the TDM group achieved significantly better
glycemic control compared to the conventional treatment group.

[Full Text Article]   [Download Certificate]


  All Since 2019
 Citation  422  322
 h-index  9  7
 i10-index  4  2



    A PHP Error was encountered

    Severity: Notice

    Message: Undefined variable: news

    Filename: views/right_panel.php

    Line Number: 79

    A PHP Error was encountered

    Severity: Warning

    Message: Invalid argument supplied for foreach()

    Filename: views/right_panel.php

    Line Number: 79


World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here